Loading clinical trials...
Loading clinical trials...
The primary goal of the trial was to evaluate whether the optimal antiproteinuric doses of benazepril (an ACE inhibitor) or losartan (an ARB), as compared with their conventional doses, can safely imp...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Southern Medical University, China
NCT00977977 · Nephrotic Syndrome, Proteinuria, and more
NCT05196035 · Chronic Kidney Disease, Proteinuria
NCT04456816 · Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy, Severe Proteinuria Due to Idiopathic Membranous Nephropathy
NCT07219121 · Proteinuria, Immunoglobulin A (IgA) Nephropathy, and more
NCT06007248 · Coronary Artery Disease, Coronary Artery Stenosis, and more
Renal Division, Nanfang Hospital,Southern Medical University
Guangzhou, Guangdong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions